• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM Back to Search Results
Model Number 102208-919
Device Problem Calibration Problem (2890)
Patient Problem Hypoglycemia (1912)
Event Date 03/01/2023
Event Type  Injury  
Manufacturer Narrative
This report is being submitted retrospectively as part of internal review.The investigation analysis was performed on the user synced glucose data on data management system (dms), which is an eversense cloud platform.Based on the investigation analysis, the reported event could not be confirmed as there was no blood glucose (bg) or the calibration entry of 2.8 mmol/l at the time of event.The system was displaying 6 mmol/l at the time of event.The investigation analysis showed that sensor was still settling at the time of incident as it was inserted on (b)(6) 2023.Typically, in the first several days after the insertion, the wound healing response to the insertion site can lead to either a hinderance of the sensor's access to the glucose in the interstitial fluid or an initial depression of the optical signal, or both.This incident happened during initial settling period and once the sensor stabilized after insertion, the system started to perform within expectations.The current sensor performance is within expectations.No further investigation was found necessary for this complaint.
 
Event Description
Senseonics was made aware of a hypoglycemia event where the patient was not alerted by the eversense cgm system likely due to sensor inaccuracies.The patient reported that the blood glucose (bg) value was 2.8 mmol/l and the sensor glucose (sg) value was 6.09 mmol/l.The patient felt symptoms of hypo, but was able to self resolved by taking carbs.The patient did not require any medical attention.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE TRANSMITTER
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20876-7005
MDR Report Key18117157
MDR Text Key327886108
Report Number3009862700-2023-00254
Device Sequence Number1
Product Code QHJ
Combination Product (y/n)Y
Reporter Country CodeSZ
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 11/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/11/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date09/13/2023
Device Model Number102208-919
Device Catalogue NumberFG-3500-09-101
Device Lot Number132075
Was Device Available for Evaluation? Yes
Date Manufacturer Received04/14/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/13/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-